Many pharmaceuticals work by targeting what are known as “G-protein-coupled receptors”. In a new study, scientists from Uppsala University describe how they have been able to predict how special molecules that can be used in new immunotherapy against cancer bind to these receptors. The researchers’ calculation methods, presented in the journal Angewandte Chemie are a vital contribution to future structure-based drug design.
- New drug combination shows promise as powerful treatment for AML
- Childhood neglect leaves generational imprint
- New approach emerges to better classify, treat brain tumors
- Certain parenting behaviors associated with positive changes in well-being during COVID-19 pandemic
- Do children view punishment as rehabilitative? A new study takes a look